Shares of Healios K.K. (OTCMKTS:HLOSF – Get Free Report) rose 5.6% during mid-day trading on Thursday . The company traded as high as 0.99 and last traded at 0.99. Approximately 200 shares changed hands during trading, a decline of 84% from the average daily volume of 1,260 shares. The stock had previously closed at 0.94.
Healios K.K. Stock Performance
The company has a 50-day moving average of 0.94 and a 200-day moving average of 1.27.
Healios K.K. Company Profile
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
See Also
- Five stocks we like better than Healios K.K.
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Hasbro’s Management Made All the Right Calls This Quarter
- What Do S&P 500 Stocks Tell Investors About the Market?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What Are Trending Stocks? Trending Stocks Explained
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
